2BM2 image
Deposition Date 2005-03-09
Release Date 2005-03-22
Last Version Date 2024-11-13
Entry Detail
PDB ID:
2BM2
Keywords:
Title:
human beta-II tryptase in complex with 4-(3-Aminomethyl-phenyl)- piperidin-1-yl-(5-phenethyl- pyridin-3-yl)-methanone
Biological Source:
Source Organism:
HOMO SAPIENS (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.20 Å
R-Value Free:
0.25
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
P 41
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:HUMAN BETA2 TRYPTASE
Gene (Uniprot):TPSB2
Chain IDs:A, B, C, D
Chain Length:245
Number of Molecules:4
Biological Source:HOMO SAPIENS
Ligand Molecules
Primary Citation
Structure Based Design of 4-(3-Aminomethylphenyl) Piperidinyl-1-Amides: Novel, Potent, Selective, and Orally Bioavailable Inhibitors of Bii Tryptase
Bioorg.Med.Chem. 13 2859 ? (2005)
PMID: 15781396 DOI: 10.1016/J.BMC.2005.02.014

Abstact

Tryptase is a serine protease found almost exclusively in mast cells. It has trypsin-like specificity, favoring cleavage of substrates with an arginine (or lysine) at the P1 position, and has optimal catalytic activity at neutral pH. Current evidence suggests tryptase beta is the most important form released during mast cell activation in allergic diseases. It is shown to have numerous pro-inflammatory cellular activities in vitro, and in animal models tryptase provokes broncho-constriction and induces a cellular inflammatory infiltrate characteristic of human asthma. Screening of in-house inhibitors of factor Xa (a closely related serine protease) identified beta-amidoester benzamidines as potent inhibitors of recombinant human betaII tryptase. X-ray structure driven template modification and exchange of the benzamidine to optimize potency and pharmacokinetic properties gave selective, potent and orally bioavailable 4-(3-aminomethyl phenyl)piperidinyl-1-amides.

Legend

Protein

Chemical

Disease

Primary Citation of related structures